We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Study of Normal Conditions of Use, Dosing, and Safety of Intravenous (IV) Administration of Vernakalant (MK-6621-049)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01370629
Recruitment Status : Recruiting
First Posted : June 10, 2011
Last Update Posted : January 24, 2018
Information provided by (Responsible Party):
Cardiome Pharma

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : April 2018
  Estimated Study Completion Date : August 2018